Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2026-05-10 @ 1:43 AM
Study NCT ID:
NCT00980603
Status:
UNKNOWN
Last Update Posted:
2009-09-21
First Post:
2009-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
Sponsor:
National Cancer Center, Korea
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
NCCCTS-07-296
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Sook Ryun Park/Dr.
Old Organization:
Research Institute and Hospital, National Cancer Center